Showing results (71-80 of 198) with videos related to
Sort By:
Pageof 20
Cardiology in the Young|November 28, 2012
Atrioventricular septal defects among infants in Europe: a population-based study of prevalence, associated anomalies, and survivalNikolas Christensen, Helle Andersen, Ester Garne, et al.Arthritis and Rheumatism|October 2, 2002
A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritisJohn Moore, Peter Brooks, Sam Milliken, et al.Haematologica|November 28, 2015
The addition of rituximab to fludarabine and cyclophosphamide chemotherapy results in a significant improvement in overall survival in patients with newly diagnosed mantle cell lymphoma: results of a randomized UK National Cancer Research Institute trialSimon Rule, Paul Smith, Peter W M Johnson, et al.British Journal of Haematology|December 2, 2017
Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphomaLuca Arcaini, Thierry Lamy, Jan Walewski, et al.European Journal of Medical Genetics|March 30, 2018
A sustainable solution for the activities of the European network for surveillance of congenital anomalies: EUROCAT as part of the EU Platform on Rare Diseases RegistrationAgnieszka Kinsner-Ovaskainen, Monica Lanzoni, Ester Garne, et al.European Journal of Pediatrics|June 10, 2025
Morbidity in children with major kidney anomalies: a European population-based studyEster Garne, Mads Damkjær, Anke Rissmann, et al.Leukemia & Lymphoma|January 4, 2018
Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS studyPaula Cramer, Graeme Fraser, Rodrigo Santucci-Silva, et al.Blood|November 12, 2020
Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trialSteven Le Gouill, Franck Morschhauser, David Chiron, et al.Journal of Clinical Medicine|June 10, 2023
Unravelling the Clinical Co-Morbidity and Risk Factors Associated with Agenesis of the Corpus CallosumCallum J Smith, Zoey G Smith, Hania Rasool, et al.Prenatal Diagnosis|October 18, 2015
Prevalence of defined ultrasound findings of unknown significance at the second trimester fetal anomaly scan and their association with adverse pregnancy outcomes: the Welsh study of mothers and babies population-based cohortLisa Hurt, Melissa Wright, Frank Dunstan, et al.Pageof 20